계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Hrain Biotechnology
company
About
Hrain Biotechnology is adhering to the concept of treating diseases and saving people.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥200M
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Hrain Biotechnology is a tumor immunotherapy technology developer, using the tumor immunotherapy technology CAR-T to provide cancer patients with precise treatment based on biological and cellular technology, and built centers in Beijing, Jiangsu, Chongqing, Henan and other places. Clinical trial platform.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥200M
Hrain Biotechnology has raised a total of
¥200M
in funding over 2 rounds. Their latest funding was raised on
Sep 30, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 30, 2019 | Series B | ¥200M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Hrain Biotechnology is funded by 2 investors.
ChiNext Qianhai Capital
and Junchenda Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
